Virbac S.A.
VRBCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,743 | $2,198 | $3,156 | $3,235 |
| - Cash | $150 | $176 | $177 | $173 |
| + Debt | $307 | $120 | $90 | $94 |
| Enterprise Value | $2,900 | $2,142 | $3,069 | $3,156 |
| Revenue | $1,397 | $1,247 | $1,216 | $1,064 |
| % Growth | 12.1% | 2.5% | 14.3% | – |
| Gross Profit | $938 | $810 | $795 | $713 |
| % Margin | 67.1% | 64.9% | 65.4% | 67% |
| EBITDA | $276 | $231 | $218 | $208 |
| % Margin | 19.8% | 18.5% | 18% | 19.6% |
| Net Income | $145 | $121 | $122 | $113 |
| % Margin | 10.4% | 9.7% | 10% | 10.6% |
| EPS Diluted | 17.34 | 14.38 | 14.43 | 13.4 |
| % Growth | 20.6% | -0.3% | 7.7% | – |
| Operating Cash Flow | $204 | $119 | $99 | $130 |
| Capital Expenditures | -$80 | -$41 | -$54 | -$47 |
| Free Cash Flow | $124 | $78 | $45 | $83 |